Skip to main content
Premium Trial:

Request an Annual Quote

David Altshuler

CRISPR Therapeutics has added David Altshuler to its Board of Directors, where he will hold an observer seat. Altshuler is Executive VP of Global Research and CSO at Vertex Pharmaceuticals. He joins the board following Vertex's acquisition of an ownership stake in CRISPR Therapeutics.